526
Participants
Start Date
December 31, 2006
Primary Completion Date
June 30, 2008
Study Completion Date
June 30, 2008
terbinafine
Terbinafine hydrochloride (HCl) 10 % nail solution for onychomycosis (NSO) once daily for 48 weeks
Placebo
Vehicle (placebo) once daily for 48 weeks
terbinafine
Terbinafine hydrochloride (HCl) 10 % Nail Solution for Onychomycosis once daily for 24 weeks
Placebo
Vehicle (placebo) once daily for 24 weeks
Dr. Richard Scher, New York
Dr. Max Weisfeld, Baltimore
Dr. Patrick Agnew, Virginia Beach
Dr. Joseph Jorrizo, Winston-Salem
Dr. Patricia Westmorland, Simpsonville
Dr. Mark Ling, Newnan
Dr. Robert P. Dunne, Melbourne
Dr. David Horowitz, Nashville
Dr. Anne Lucky, Cincinnati
Dr. Linda Stein-Gold, Detroit
Dr. Jesse Plasencia, Chicago
Dr. Anna Glaser, St Louis
Dr. John Mallory, Overland Park
Dr. Jeffrey Conrow, Topeka
Dr.Michael Kaye, Covington
Dr. Jay Lifshen, Irving
Dr. Richard Pollak, San Antonio
Dr. Larry Doehring, Northglenn
Dr. Fred D. Youngswick, Novato
Dr. Rich Phoebe, Portland
Novartis Investigative Site, Various Cities
Novartis, Investigative Site
Novartis Investigative Site, Various Cities
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY